Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)
15 November 2022 - 9:47AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO
RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of November 2022
Commission File Number: 001-39034
BELLUS HEALTH INC.
(Translation of registrant’s name into
English)
275 Armand-Frappier Blvd.
Laval, Québec
H7V 4A7
Canada
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual
reports under cover of Form 20-F or Form 40-F.
INCORPORATION BY REFERENCE
On November 14, 2022, the Registrant entered into
an Open Market Sale AgreementSM with Jefferies LLC, a copy of which is attached hereto as Exhibit 99.1, and which is incorporated
by reference to the Registrant’s Registration Statement on Form F-10 (File No. 333-267106), as amended and supplemented.
SIGNATURES
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
BELLUS Health Inc. |
|
|
|
|
Date: November 14, 2022 |
By: |
/s/ Ramzi Benamar |
|
|
Name: |
Ramzi Benamar |
|
|
Title: |
Chief Financial Officer |
Form 6-K Exhibit Index
BELLUS Health (NASDAQ:BLU)
Historical Stock Chart
From Apr 2024 to May 2024
BELLUS Health (NASDAQ:BLU)
Historical Stock Chart
From May 2023 to May 2024